Recently, astaxanthin has been reported to increase the expression of miR-29a-3p and miR-200a in colorectal cancer, thereby targeting MMP2 and ZEB1 and eventually inhibiting the epithelial-mesenchymal transition of cancer cells [15]. Here, ZEB1 is linked to cancer.